Transcatheter heart valve implantation is a procedure with less invasive approach helps in replacing the heart valve with prosthetic valve for treatment of severe aortic stenosis and mitral regurgitation.
The prime driver for the transcatheter heart valve replacement & repair market is rising demand for less invasive procedure for high risk patients, growing prevalence of mitral regurgitation and severe aortic stenosis disorder.
The global Transcatheter Heart Valve Replacement and Repair market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Transcatheter Heart Valve Replacement and Repair volume and value at global level, regional level and company level. From a global perspective, this report represents overall Transcatheter Heart Valve Replacement and Repair market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Transcatheter Heart Valve Replacement and Repair in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Transcatheter Heart Valve Replacement and Repair manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
St. Jude Medical
Segment by Regions
Segment by Type
Transcatheter Aortic Valve Replacement (TAVR)
Transcatheter Mitral Valve Repair (TMVR)
Segment by Application
Ambulatory Surgical Centers
Cardiac Catheterization Laboratory